SCV
CINC

Sands Capital Ventures’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Sands Capital Ventures’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-950,000
Closed -$17.9M – 19
2022
Q2 		$17.9M Hold
950,000
– – 4.91% 9
2022
Q1 		$16.7M Buy
+950,000
New +$19.5M 3.48% 8

Other funds holding CINC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sands Capital Ventures's CINC Position: Q3 2022 in Review

Sands Capital Ventures sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q3 2022, closing a stake of 950,000 shares — an estimated $17.9M sold.

Sands Capital Ventures first reported a position in CINC in Q1 2022 and held it in 2 quarters. The position peaked at $17.9M in Q2 2022. 86 funds tracked by Wall St. Rank hold CINC as of Q3 2022.

  • Sands Capital Ventures reported no remaining CinCor Pharma, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Sands Capital Ventures sold 950,000 CinCor Pharma, Inc. Common Stock shares in Q3 2022, an estimated $17.9M.
  • Sands Capital Ventures first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Sands Capital Ventures's CinCor Pharma, Inc. Common Stock position peaked at $17.9M in Q2 2022.
  • 86 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q3 2022.

Based on Sands Capital Ventures's 13F filing for Q3 2022, filed 9 Nov 2022.